| # | Drug | Count |
|---|---|---|
| 0 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 344 |
| 1 | TREPROSTINIL | 162 |
| 2 | PRABOTULINUM TOXIN TYPE A | 105 |
| 3 | 0XYGEN | 100 |
| 4 | OXYGEN | 100 |
| 5 | ERGOCALCIFEROL | 83 |
| 6 | FUROSEMIDE | 81 |
| 7 | BRODALUMAB | 80 |
| 8 | LEVOTHYROXINE SODIUM | 78 |
| 9 | ASPIRIN | 69 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 344 | 0.0405 |
| 1 | BRODALUMAB | 80 | 0.0388 |
| 2 | PRABOTULINUM TOXIN TYPE A | 105 | 0.0278 |
| 3 | PERFLUOROHEXYLOCTANE | 56 | 0.0241 |
| 4 | EFINACONAZOLE | 24 | 0.0122 |
| 5 | PLECANATIDE | 25 | 0.0120 |
| 6 | DEOXYCHOLIC ACID | 13 | 0.0056 |
| 7 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 14 | 0.0044 |
| 8 | AVATROMBOPAG MALEATE | 10 | 0.0042 |
| 9 | ESTRADIOL AND LEVONORGESTREL | 8 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 160 |
| 1 | Acetylcholine Release Inhibitor [EPC] | 155 |
| 2 | Neuromuscular Blocker [EPC] | 155 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 136 |
| 4 | Loop Diuretic [EPC] | 101 |
| 5 | Provitamin D2 Compound [EPC] | 83 |
| 6 | Corticosteroid [EPC] | 81 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 80 |
| 8 | Osmotic Laxative [EPC] | 77 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 28 | 0.0407 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 80 | 0.0388 |
| 2 | Semifluorinated Alkane [EPC] | 56 | 0.0241 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 28 | 0.0135 |
| 4 | Cytolytic Agent [EPC] | 13 | 0.0056 |
| 5 | Provitamin D2 Compound [EPC] | 83 | 0.0028 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 40 | 0.0024 |
| 7 | Leptin Analog [EPC] | 2 | 0.0016 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 155 | 0.0016 |
| 9 | Human Immunoglobulin G [EPC] | 30 | 0.0014 |